Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 5Phase 1/2 3Phase 2/3 1Phase 1 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 2Lymphoid 1Genitourinary 1

Conditions

Wilms Tumor 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Specimen Handling 176Magnetic Resonance Spectroscopy 138Biopsy 102pembrolizumab 81Carboplatin 79Cisplatin 71Nivolumab 65Cyclophosphamide 64Paclitaxel 54Radiotherapy 48Gemcitabine 43durvalumab 39Doxorubicin 35Bevacizumab 34Fluorouracil 33venetoclax 32Dexamethasone 31Rituximab 30atezolizumab 29Radiation 29Capecitabine 28Lenalidomide 27Etoposide 27Prednisone 26Oxaliplatin 26Injections 26Pemetrexed 25Docetaxel 25olaparib 23fludarabine 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Ifosfamide × 30 days × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

NCT00077285 2026-05-22

Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
65 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

NCT05221645 2026-05-15

P+R-ICE

University of Southampton

Phase 2 Active not recruiting
65 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04322318 2026-05-05

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Children's Oncology Group

Phase 2 Recruiting
256 enrolled
Genitourinary

Wilms Tumor

NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡